Company intelligence / Profile preview

Rogosin Institute

New York City, New York, United Statesrogosin.org ↗

Ownership: Private
Employees: ~352
Development stage: Commercial

Overview

The Rogosin Institute is a leading not-for-profit center specializing in the diagnosis, management, and treatment of chronic and end-stage kidney diseases. It operates one of the largest home dialysis programs in New York City and has pioneered innovative approaches such as home nocturnal hemodialysis and LDL-apheresis for lipid disorders. Its Immunogenetics and Transplantation Laboratory is among the largest solid-organ immunogenetics labs in the Northeast, supporting transplantation compatibility testing for numerous centers[2][3][7].

Therapeutic areas: CardiovascularNephrology
Modalities: Device (dialysis systems)Biologic (LDL-apheresis)
Industry: Academic Hospital/University/Research

Partnerships

NewYork-Presbyterian HospitalWeill Cornell Medical College

Beyond the preview

Go deeper on Rogosin Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rogosin Institute.

Explore the full profile